![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsors and Collaborators: |
GlaxoSmithKline Parexel Northwick Park |
Information provided by: | GlaxoSmithKline |
ClinicalTrials.gov Identifier: | NCT00687700 |
Study will investigate the pharmacodynamics of a dual pharmacophore in which a combination of GSK961081 and Propanolol is used to give a total effect of bronchodilation.
Condition | Intervention | Phase |
Healthy Volunteers |
Drug: GSK961081 Drug: Propanolol |
Phase I |
ChemIDplus related topics: | Propranolol Dexpropranolol Propranolol hydrochloride |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Pharmacodynamics Study |
Official Title: | A Study to Investigate the Relative Pharmacological Activity of an Inhaled B2-Agonist/Anticholinergic Dual Pharmacophore in Healthy Volunteers |
Estimated Enrollment: | 23 |
Study Start Date: | February 2008 |
Estimated Study Completion Date: | May 2008 |
Estimated Primary Completion Date: | May 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years to 50 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United Kingdom, London | |||||
GSK Clinical Trials Call Center | Recruiting | ||||
Harrow, London, United Kingdom, HA1 3UJ | |||||
Contact: GSK Clinical Trials Call Centre 1-877-379-3718 |
GlaxoSmithKline |
Parexel Northwick Park |
Study Director: | GSK Clinical Trials, MD MSc FFPM | GlaxoSmithKline |
Study ID Numbers: | MAB110553 |
First Received: | May 28, 2008 |
Last Updated: | May 30, 2008 |
ClinicalTrials.gov Identifier: | NCT00687700 |
Health Authority: | United Kingdom: Research Ethics Committee |
|
|
|
|
![]() |